Publicaties Parelsnoer Instituut

  

Parel

Auteur(s)/Titel/Referentie

Cerebrovasculair Accident (CVA)

Hauer AJ, Ruigrok YM, Algra A, Dijk EJ van, Koudstaal PJ, Luijckx G, Nederkoorn PJ, Oostenbrugge RJ van, Visser MC, Wermer MJ, Kappelle LJ, Klijn CJM; On behalf of the Dutch Parelsnoer Institute-Cerebrovascular Accident Study Group. Age-specific vascular risk factor profiles according to stroke subtype. J Am Heart Assoc 2017;6:e005090.

Nederkoorn PJ, van Dijk EJ, Koudstaal PJ, Luijckx GJ, van Oostenbrugge RJ, Visser MC, Wermer MJ, Ruigrok YM, Algra A, Kappelle LJ; Dutch String-of-Pearls Stroke Study-Group. The Dutch String-of-Pearls Stroke Study: protocol of a large prospective multicenter genetic cohort study. Int J Stroke 2015;10(1):120-2.

CONCOR

Schoormans D, Sprangers MA, van Melle JP, Pieper PG, van Dijk AP, Sieswerda GT, Hulsbergen-Zwarts MS, Plokker TH, Brunninkhuis LG, Vliegen HW, Mulder BJ. Clinical and psychological characteristics predict future healthcare use in adults with congenital heart disease. Eur J Cardiovasc Nurs 2016;15(1):72-81.

Bokma JP, Winter MM, Mulder BJ, Bouma BJ. Tricuspid Regurgitation Secondary to Severe Pulmonary Regurgitation: When to Operate on Which Valves? Ann Thorac Surg 2015;100(6):2417-2418.

Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Hazekamp MG, Koolbergen DR, Groenink M, Mulder BJ, Bouma BJ. Preoperative thresholds for mid-to-late haemodynamic and clinical outcomes after pulmonary valve replacement in tetralogy of Fallot. Eur Heart J 2016;37(10): 829-835.

Blok IM, van Riel AC, Mulder BJ, Bouma BJ. Management of patients with pulmonary arterial hypertension due to congenital heart disease: recent advances and future directions. Expert Rev Cardiovasc Ther 2015;13(12):1377-92. 

van Riel AC, Blok IM, Zwinderman AH, Wajon EM, Sadee AS, Bakker-de Boo M, van Dijk AP, Hoendermis ES, Riezebos RK, Mulder BJ, Bouma BJ. Lifetime Risk of Pulmonary Hypertension for All Patients After Shunt Closure. J Am Coll Cardiol 2015; 66(9):1084-1086.

Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Hazekamp MG, Koolbergen DR, Groenink M, Mulder BJ, Bouma BJ. Individualised prediction of pulmonary homograft durability in tetralogy of Fallot. Heart 2015;101(21):1717-1723.

Franken R, Mulder BJ. Aortic disease: Losartan versus atenolol in the Marfan aorta-how to treat? Nat Rev Cardiol 2015;12:447-448. 

van Riel AC, de Bruin-Bon RH, Gertsen EC, Blok IM, Mulder BJ, Bouma BJ. Simple stress echocardiography unmasks early pulmonary vascular disease in adult congenital heart disease. Int J Cardiol 2015;197:312-314.

Bokma JP, Winter MM, Oosterhof T, Vliegen HW, van Dijk AP, Hazekamp MG, Koolbergen DR, Groenink M, Mulder BJ, Bouma BJ. Severe tricuspid regurgitation is predictive for adverse events in tetralogy of Fallot. Heart 2015;101:794-799.

Blok IM, van Riel AC, Schuuring MJ, Duffels MG, Vis JC, van Dijk AP, Hoendermis ES, Mulder BJ, Bouma BJ. Decrease in quality of life predicts mortality in adult patients with pulmonary arterial hypertension due to congenital heart disease. Neth Heart J 2015;23(5):278-284.

Franken R, El Morabit A, de Waard V, Timmermans J, Scholte AJ, van den Berg MP, Marquering H, Planken NR, Zwinderman AH, Mulder BJ, Groenink M. Increased aortic tortuosity indicates a more severe aortic phenotype in adults with Marfan syndrome. Int J Cardiol 2015;194:7-12.

Sluman MA, Apers S, Bouma BJ, van Melle JP, Peels CH, Post MC, Waskowsky WM, Moons P, Mulder BJ. Uncertainties in insurances for adults with congenital heart disease. Int J Cardiol 2015;186:93-95.

Kuijpers JM, Mulder BJ, Bouma BJ. Secundum atrial septal defect in adults: a practical review and recent developments. Neth Heart J 2015;23(4):205-211.

Kuijpers JM, van der Bom T, van Riel AC, Meijboom FJ, van Dijk AP, Pieper PG, Vliegen HW, Waskowsky WM, Oomen T, Zomer AC, Wagenaar LJ, Heesen WF, Roos-Hesselink JW, Zwinderman AH, Mulder BJ, Bouma BJ. Secundum atrial septal defect is associated with reduced survival in adult men. Eur Heart J 2015;36(31):2079-2086.

Kampman MA, Balci A, Groen H, van Dijk AP, Roos-Hesselink JW, van Melle JP, Sol-lie-Szarynska KM, Wajon EM, Mulder BJ, van Veldhuisen DJ, Pieper PG; ZAHARA II investigators. Cardiac function and cardiac events 1-year postpartum in women with congenital heart disease. Am Heart J 2015;169(2):298-304.

den Hartog AW, Franken R, Zwinderman AH, Timmermans J, Scholte AJ, van den Berg MP, de Waard V, Pals G, Mulder BJ, Groenink M. The risk for type B aortic dissection in marfan syndrome. J Am Coll Cardiol 2015;65(3):246-254.

Franken R, den Hartog A, Radonic T, Micha D, Maugeri A, van Dijk FS, Meijers-Heijboer HE, Timmermans J, Scholte AJ, van den Berg MP, Groenink M, Mulder BJ, Zwinderman AH, de Waard V, Pals G. Beneficial Outcome of Losartan Therapy Depends on Type of FBN1 Mutation in Marfan Syndrome. Circ Cardiovasc Genet 2015;8:383-388.  

van der Bom T, Winter MM, Knaake JL, Cervi E, de Vries LS, Balducci A, Meregalli PG, Pieper PG, van Dijk AP, Bonvicini M, Mulder BJ, Bouma BJ. Long-term benefits of exercise training in patients with a systemic right ventricle. Int J Cardiol 2015;179:105-111.

Luijendijk P, Lu H, Heynneman FB, Huijgen R, de Groot EE, Vriend JW, Vliegen HW, Groenink M, Bouma BJ, Mulder BJ. Increased carotid intima-media thickness predicts cardiovascular events in aortic coarctation. Int J Cardiol 2014;176(3):776-781.

Koyak Z, Kroon B, de Groot JR, Wagenaar LJ, van Dijk AP, Mulder BA, van Gelder IC, Post MC, Mulder BJ, Bouma BJ. Efficacy of antiarrhythmic drugs in adults with congential heart disease and supraventricular tachycardias. Am J Cardiol 2013;112(9):1461-1467.

Mulder BJ. Endocarditis in congenital heart disease: who is at highest risk? Circulation 2013;128:1396-1397.

Mamasoula C, Prentice RR, Pierscionek T, Pangilinan F, Mills JL, Druschel C, Pass K, Russel MW, Hall D, Topf A, Brown DL, Zelenika D, Bentham J, Cosgrove C, Bhattacharya S, Riveron JG, Setchfield K, Brook JD, Bu'Lock FA, Thornborough C, Rahman TJ, Doza JP, Than HL, O'Sullivan J, Stuart AG, Blue G, Winlaw D, Postma AV, Mulder BJ, Zwinderman AH. van Engelen K, Moorman AF, Rauch A, Gewillig M, Breckpot J. Devriendt K, Lathrop GM, Farrall M, Goodship JA, Cordell HJ, Brody LC, Keavney BD. Association between C677T Polymorphism of Methylene Tetrahydrofolate Reductase and Congenital Heart Disease: Meta-Analysis of 7697 Cases an 13 125 Controls. Circ Cardiovasc Genet 2013;6:347-353. 

van Slooten YJ, Freling HG, van Melle JP, Mulder BJ, Jongbloed MR, Ebels T, Voors AA, Pieper PG. Long-term tricuspid valve prothesis-related complications in patients with congenital heart disease. Eur J Cardiothorac Surg 2014;45(1):83-89.

Joziasse IC, Vink A, Cramer MJ, van Oosterhout MF, van Herwerden LA, Heijmen R, Sieswerda GT, Mulder BJ, Doevendans PA. Bicuspid stenotic aortic valves: clinical characteristics and morphological assessment using MRI and echocardiography. Neth Heart J 2011;19(3):119-125.

Diabetes

van 't Riet E, Schram MT, Abbink EJ, Admiraal WM, Dijk-Schaap MW, Holleman F, Nijpels G, Özcan B, Pijl H, Schaper NC, Sijbrands EJ, Silvius B, Tack CJ, de Valk HW, Wolffenbuttel BH, Stehouwer CD, Dekker JM. The Diabetes Pearl: Diabetes biobanking in The Netherlands. BMC Public Health 2012;12:949.

Erfelijke darmkanker (BED)

Hoogerbrugge N, Manders P. Biobank Erfelijke Darmkanker (BED) Parelsnoer Initiatief. Hèt HNPCC-Lynch journaal 2010;7(4):27-28.

Inflammatoire darmziekten (IBD)

Visschedijk MC, Alberts R, Mucha S, Deelen P, de Jong DJ, Pieriks M, Spekhorst LM, Imhann F, van der Meulen-de Jong AE, van der Woude J, van Bodegraven AA, Oldenburg B, Löwenberg M, Dijkstra G, Ellinghaus D, Schreiber S, Wijmenga C, The Initiative on Crohn and Colitis, Parelsnoer Institute, Rivas MA, Franke A, van Diemen CC, Weersma RK. Pooled Resequencing of 122 Ulcerative Colitis Genes in a Large Dutch Cohort Suggests Population-Specific Associations of Rare Variants in MUC2. PLoS One 2016;11(8):e0159609.

Severs M, Erp SJH van, Valk ME van der, Mangen MJJ, Fidder HH, Have van der M, Bodegraven AA van, Jong DJ de, Woude CJ van der, Romberg-Camps MJL, Clemens CHM, Jansen JM, Meeberg PC van de, Mahmmod N, Ponsioen CY, Bolwerk C, Vermeijden JR, Pierik MJ, Siersema PD, Leenders M, Meulen-de Jong AE van der, Dijkstra G, Oldenburg B, on behalf of the Dutch Initiative on Crohn and Colitis. Smoking is associated with extra-intestinal manifestations in inflammatory bowel disease. J Crohns Colitis 2016;10(4):455-461.

Neurodegeneratieve hersenziekten (NDZ)

Aalten P, Ramakers IH, Biessels GJ, de Deyn PP, Koek HL, OldeRikkert MG, Oleksik AM, Richard E, Smits LL, van Swieten JC, Teune LK, van der Lugt A, Barkhof F, Teunissen CE, Rozendaal N, Verhey FR, van der Flier WM. The Dutch Parelsnoer Institute - Neurodegenerative diseases; methods, design and baseline results. BMC Neurol 2014;14:254.

Nierfalen

Navis GJ, Blankestijn PJ, Deegens J, De Fijter JW, Homan van der Heide JJ, Rabelink T, Krediet RT, Kwakernaak AJ, Laverman GD, Leunissen KM, van Paassen P, Vervloet MG, Wee PM, Wetzels JF, Zietse R, van Ittersum FJ. The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands. Nephrol Dial Transplant 2014;29(6):1145-50.  

Oesofagus Maag tumoren

Haverkamp L, Parry K, van Berge Henegouwen MI, van Laarhoven HW, Bonenkamp JJ, Bisseling TM, Siersema PD, Sosef MN, Stoot JH, Beets GL, de Steur WO, Hartgrink HH, Verspaget HW, van der Peet DL, Plukker JT, van Etten B, Wijnhoven BP, van Lanschot JJ, van Hillegersberg R, Ruurda JP. Esophageal and Gastric Cancer Pearl: a nationwide clinical biobanking project in the Netherlands. Dis Esophagus 2016;29:435-441.

Parkinson

De Monchy N. Nederlands Parkinson Cohort: Een unieke onderzoekssamenwerking van zeven Parkinsoncentra - Parkinson Magazine 2015;1:6-7.

Reuma

Wier MF van, Huizinga TWJ, Brouwer E, Boonen A, Fransen J, Marijnissen ACA, Blaas EWF, Maijer KI, Vries N de, Bijlsma JWJ, Lems WF, Nurmohamed MT, Helm-van Mil AHM van der, Hazes JMW. De Parel Reuma, het register en biobank voor vroege artritis patiënten van de Nederlandse UMC’s. Nederlands Tijdschrift voor Reumatologie 2016;2:32-39.

 

           Overig

 

Auteur(s)/Titel/Referentie

Zielhuis G. Proeven met mensen: Biobanken. Biowetenschappen en Maatschappij 2017;36(2):69-73.

Manniën J, Ledderhof T, Verspaget HW, Snijder RR, Flikkenschild EF, Scherrenburg NPC van, Stolk RP, Zielhuis GA. The Parelsnoer Institute: a national network of standardized clinical biobanks in The Netherlands. OJB 2017;4(1):3.

Douglas CM, Scheltens P. Rethinking biobanking and translational medicine in the Netherlands: how the research process stands to matter for patient care. Eur J Hum Genet 2015;23(6):736-8.

Zielhuis GA, Ledderhof TM. Het Parelsnoer Instituut, een ketting van biobanken van alle UMC’s. CaRré 2014;19(61):35-37.

Jagmohan-Changur S, van der Reijden J, Verspaget H. Parelsnoer biobank: een schatkamer voor wetenschappelijk onderzoek! De blauwdruk van het LUMC. Analyse 2013;68(10):300-305.

Buiter R. Betere medicijnen met biobank. Medicines 2013;6:16-17.

Zielhuis GA. Biobanking for Epidemiology. Public Health 2012;26(3)214-216.

Boeckhout M, van Dijk J, Legemate DA. Toetsing van biobanken: lessen uit het Parelsnoer Initiatief. Ned Tijdschr Geneeskd 2011;155:A3557. 

Talmon JL, Ros MG, Legemate DA. The Dutch Academic Infrastructure for shared biobanks for translational research. Summit on Translat Bioinforma 2008;2008:110-4.